Evidence that the modulator of the glucocorticoid-receptor complex is the endogenous molybdate factor 
glucocorticoid receptor. Since these activities are shared by exogenous sodium molybdate, modulator appears to be the endogenous factor that sodium molybdate mimics. In this report, we present additional evidence for the mechanism of action of purified modulator. (i) Molybdate and modulator inhibit receptor activation as measured by DNA-cellulose binding, DEAE-cellulose chromatography, and Sepharose 4B gel filtration. (ii) The ability of molybdate and modulator to inhibit receptor activation and stabilize the unoccupied receptor appears to be additive. (iii) Scatchard analysis of heatdestabilized unoccupied receptors indicates that the number of steroid-binding sites is reduced during destabilization, whereas the steroid dissociation constant remains unchanged. Molybdate and modulator stabilize the receptor by maintaining the number of steroid-binding sites. (iv) Molybdate and modulator do not inhibit alkaline phosphatase-induced destabilization of the unoccupied receptor. However, alkaline phosphatase-induced destabilization is reversed by the addition of dithiothreitol in the presence, but not in the absence, of molybdate or modulator. These results suggest that the mechanism of action for modulator is identical to that of sodium molybdate, and we propose that modulator is the endogenous molybdate factor for the glucocorticoid receptor.
Modulator is commonly known as the low molecular weight heat-stable inhibitor of glucocorticoid-receptor complex (GRC) activation (or transformation). Activation is the process by which the steroid-receptor complex is converted to its DNA-binding form (1, 2) . In 1976 our laboratory reported the existence of modulator (3) , and since our initial finding (4, 5) , several other laboratories have also observed this activation inhibitor in crude or partially purified preparations (6) (7) (8) (9) (10) (11) (12) (13) (14) . In addition to inhibiting GRC activation, crude or partially purified preparations of modulator also stabilize the steroid-binding ability of the unoccupied glucocorticoid receptor (UGR; refs. 9 and 15).
Exogenous sodium molybdate (Na2MoO4) has also been observed to inhibit GRC activation and stabilize the UGR (13, 14, 16) . It is not known why Na2MoO4 has these activities, but it is generally thought that molybdate interacts directly with the glucocorticoid receptor (13, 14, (17) (18) (19) . Furthermore, Na2MoO4 also inhibits the activation and stabilizes the steroid binding of other steroid hormone receptors (13, 14) .
We have reported the complete purification of modulator from rat liver (20) . Purified modulator is an ether aminophosphoglyceride that inhibits rat liver GRC activation and stabilizes the steroid-binding ability of the UGR from rat liver. These observations suggest that modulator is the endogenous factor that exogenous Na2MoO4 mimics in this steroid receptor system.
In the present study, we sought to further characterize the mechanism of action for modulator on the rat liver glucocorticoid receptor. Our results suggest that purified modulator and Na2MoO4 behave identically in their ability to inhibit GRC activation and stabilize the steroid binding of the UGR. From this work, we propose a model for the mechanism of action of modulator and molybdate.
EXPERIMENTAL PROCEDURES
Animals, Preparation of Cytosol, and Steroid Binding. Rat liver cytosol was prepared from adrenalectomized male Sprague-Dawley rats (Charles River Breeding Laboratories) as described (21) , except that buffer A (50 mM KH2PO4/5 mM dithiothreitol/10 mM thioglycerol/10 mM Na2MoO4, pH 7.0) was used in the present study. Aliquots of cytosol were incubated with 100 nM [6,7- Stabilization of Steroid-Binding Assay. One-milliliter aliquots of unlabeled cytosol were filtered through Sephadex G-25 columns equilibrated with either buffer B or buffer C as described above. Fifty microliters of this cytosol was mixed with ice-cold buffer C and sample or water also as described above. This mixture was incubated at 20'C for 1 hr, at which time 20 mM Na2MoO4 was added to stop destabilization, and the samples were placed on ice. Two-hundred-microliter aliquots were removed for [3HJTA binding that was or was not blocked by competition (10 nM [3H]TA + 5 AM radioinert TA) and subsequent HAP binding (75 Al per assay).
The specific [3H]TA binding is typically <80%o for the 20'C buffer control, and >95% for the 0C + 20 mM Na2MoO4 buffer control.
Purification of Modulator. Modulator was isolated by large-scale purification (20) .
DEAE-Cellulose Chromatography. DEAE-cellulose (Whatman DE-52) chromatography was performed in a cold room on 3-ml bed volume columns as described (22), except that KH2PO4/10 mM Na2MoO4, pH 7.0, buffer was used. The column was equilibrated with 5 mM KH2PO4 buffer, the 0.5-ml samples were applied, and the columns were washed with 10 ml of 5 mM KH2PO4 buffer. The columns were eluted with a linear 5-400 mM KH2PO4 gradient, and 1-ml fractions were collected at a flow rate of 1 ml/min. After the conductivity of the fractions was determined, 0.5 ml of each fraction was mixed with 5 ml of liquid scintillation fluid for measurement of 3H.
Sepharose 4B Gel Filtration. Sepharose 4B (Pharmacia) gel filtration was performed in a cold room on a 10-ml bed volume column equilibrated with 50 mM KH2PO4/1 mM thioglycerol/10 mM Na2MoO4/400 mM KCl, pH 7.0, buffer. A 0.1-ml sample was applied and eluted at a flow rate of 0.5 ml/min, 0.25-ml fractions were collected, and 3H was measured by liquid scintillation spectroscopy in 6-ml vials.
Alkaline Phosphatase-Induced Destabilization. The stabilization assay was performed as described above, except that 10 ,ug of Escherichia coli alkaline phosphatase (type III-R, electrophoretically prepared, Sigma) per ml was added to each reaction mixture. The alkaline phosphatase suspension [0.5 ml in 2.6 M (NH4)2SO41 was first chromatographed on a 10-ml bed volume Sephadex G-25 column equilibrated with buffer C to remove the salt. Enzyme activity was tested by using 4-nitrophenyl phosphate hydrolysis (1 mM in buffer C, 10 ,ug of enzyme per ml, 25°C for 4 hr) and detection at 410 nm. Contaminating protease activity was tested by using the hydrolysis of bovine serum albumin (2 mg/ml in buffer C, 10 ,ug of enzyme per ml, 25°C for 4 hr) followed by 10o perchloric acid precipitation and detection of acid-soluble protein at 280 nm.
RESULTS

GRC Activation Inhibition by Molybdate and Purified
Modulator. When unactivated rat liver [3H]TA-receptor complexes were diluted 1:10 and warmed at 15°C for 1 hr (heat-dilution activation), the ability of those receptors to bind to DNA-C increased about 10-fold ( Fig. 1 and Table 1 ). This increase in DNA-C binding was accompanied by a shift in the elution of [3H]TA-receptor complexes from 250 mM KH2PO4 (unactivated GRCs) to 75 mM KH2PO4 (activated GRCs) on DEAE-cellulose chromatography ( Fig. 1 A and B; ref. 7) . However, when heat-dilution activation was performed in the presence of 20 mM Na2MoO4 (Fig. 1C) or 20 ,uM purified modulator (Fig. 1D) , the increase in DNA-C Similarly, when unactivated [3H]TA-receptor complexes were warmed at 25°C for 30 min (heat activation), the Stokes radius of the steroid-receptor complex shifted from about 70 A (unactivated GRCs) to about 50 A (activated GRCs), as measured by Sepharose 4B gel filtration ( Fig. 2 A and B; ref.  23 ). This size shift of [3H]TA-receptor complexes, as measured by gel filtration, and the increase in DNA-C binding were inhibited when heat activation was performed in the presence of 30 mM Na2MoO4 (Fig. 2C) or 30 p.M purified modulator (Fig. 2D) .
Effects of Molybdate and Purified Modulator on GRC Activation and UGR Stabilization Are Additive. Na2MoO4 and purified modulator inhibited rat liver GRC activation in a dose-dependent manner ( Fig. 3 ). This reduction in steroid binding was prevented when heat-dilution destabilization was performed in the presence of 20 mM Na2MoO4 or 20 pM purified modulator (Table 2 and Fig. 3 ). Molybdate and modulator also stabilized the UGR in a dose-dependent manner ( Fig. 3 shows the results of a Scatchard analysis of heatdilution-destabilized receptors (24) . When UGRs were heatdilution destabilized, the specific [3H]TA binding of those receptors was reduced by a factor of about 10 (Fig. 3A) . Scatchard analysis of these data (Fig. 3B) indicated that the loss of [3H]TA binding by these receptors was due to a reduction in the number of steroid-binding sites (Bmax) and not due to an increase in the steroid dissociation constant (Kd). Twenty millimolar Na2MoO4 or 20 ,tM purified modulator stabilized the UGR by maintaining the Bmax and not by altering the Kd. The slight increase in the Kd observed with 20 FM modulator (6.3 nM vs. 3.8 + 0.5 nM) may be due to a nonspecific effect of modulator on the receptor, since this concentration of modulator is three to four times greater than the apparent concentration of modulator in rat liver cytosol. When an experiment similar to the one shown in Fig. 3 was performed with 10 tkM purified modulator, the Bmax was only 13 nM, but the Kd was 4.2 nM (data not shown). These results suggest that the mechanism of UGR stabilization by molybdate and modulator is similar. To further test this observation, the experiment in Fig. 4 was performed.
The experiment in Fig. 4 was based on earlier work by Housley et al. (25) . This group demonstrated that alkaline phosphatase-induced destabilization of UGRs, unlike heatinduced destabilization, was not inhibited by Na2MoO4 (Fig.  4; ref. 25) . However, alkaline phosphatase-induced destabilization could be reversed by dithiothreitol in the presence, but not in the absence, of Na2MoO4 (Fig. 4; ref. 25 ). This work led Housley et al. to propose that molybdate was interacting directly with the glucocorticoid receptor (25) . The data in Fig. 4 indicate that purified modulator acts in a manner similar to that of Na2MoO4. Interestingly, the rate of alkaline phosphatase-induced destabilization of the UGR was slower than the buffer control when molybdate or modulator was present. This suggests that molybdate and modulator interfere with the ability of alkaline phosphatase to dephosphorylate the receptor. However, neither 20 mM Na2MoO4 nor 20 AtM purified modulator inhibited the enzyme (data not shown; ref. 25) , and the alkaline phosphatase preparation did not contain detectable protease activity (data not shown).
DISCUSSION
The ability to purify the modulator of the GRC to apparent homogeneity has enabled us to explore the mechanism of action and analyze the chemical structure of this previously uncharacterized molecule. The results presented in this report provide evidence that strongly suggests that modulator is the endogenous molybdate factor. This conclusion is based on the following observations.
(i) Molybdate and modulator inhibit GRC activation, as measured by DNA-C binding, DEAE-cellulose chromatography, and Sepharose 4B gel filtration (Figs. 1 and 2 (ii) The effects of molybdate and modulator on GRC activation and UGR stabilization appear to be additive and are not synergistic or antagonistic (Tables 1 and 2 ). Since it is not possible to exceed 100% activity in the assays, these results suggest that molybdate and modulator may act at the same site, possibly on the receptor itself. It should be noted that the effects of molybdate and modulator on the receptor are reversed when they are removed from cytosol by Sephadex G-25 gel filtration (data not shown).
(iii) Molybdate and modulator stabilize UGRs by maintaining the number of steroid-binding sites and not by altering the steroid dissociation constant (Fig. 3) . However, molybdate and modulator do not reverse the destabilization of UGRs (data not shown). Furthermore, neither molybdate nor modulator inhibits alkaline phosphatase-induced destabilization, but alkaline phosphatase-induced destabilization is reversed by addition of dithiothreitol when molybdate or modulator is present during the enzyme incubation (Fig. 4) .
Molybdate, as well as tungstate and vanadate, has been known to stabilize the steroid-binding ability of the UGR and inhibit GRC activation for almost a decade (13, 14, 16) . However, the reason why these transition-metal oxyanions affect the glucocorticoid receptor has remained an enigma. Initially, it was thought that molybdate was inhibiting a phosphatase(s) that was involved in the dephosphorylation of the receptor (1). This dephosphorylation was thought to cause GRC activation and a reduction in the ability of the UGR to bind steroid. However, molybdate does not inhibit alkaline phosphatase-induced destabilization of the UGR (Fig. 4 ; ref. 25) , and GRC activation does not appear to proceed by way of dephosphorylation of the receptor (26, 27) . Thus, it is now thought that molybdate interacts directly with the glucocorticoid receptor (13, 14, (17) (18) (19) . Molybdate is known to be able to form complexes with sulfhydryl, carboxyl, hydroxyl, phosphate, imino, and amino groups (28, 29) . Molybdate is also known to inhibit the activation of the purified unactivated GRC (18, 19) , and Housley et al. (25) have postulated that molybdate binds to a cysteine residue on the receptor. In addition, the data in Fig. 4 suggest that molybdate (and modulator) may be binding near Alkaline phosphatase-induced destabilization was performed with gel-filtered cytosol (equilibrated with buffer C) incubated in the presence or absence of 20 mM Na2MoO4 or 20 1uM purified modulator (heat-dilution destabilization was also performed in the presence of molybdate or modulator). Dithiothreitol (DTT) (0.5 mM) was added to some of the incubations after enzyme-induced destabilization but prior to We have recently subjected purified modulator to chemical analysis, UV, IR, NMR, and MS (20) . (20) . In contrast to a recent report (30) , we find no evidence that purified modulator contains a metal such as molybdenum, vanadium, or tungsten, and modulator activity is destroyed by ashing (31).
ments have led us to propose that modulator is an ether aminophosphoglyceride that is structurally related to snglycero-3-phosphoserine (Fig. 5 ); x-ray crystallography and chemical synthesis of modulator are necessary. It is clear from this work that modulator contains carboxyl, hydroxyl, phosphate, and amino groups. These groups are capable of forming ionic interactions or hydrogen bonds with the same amino acid residues with which molybdate is capable of forming complexes. Therefore, we propose that modulator binds to the same site on the glucocorticoid receptor to which molybdate is thought to bind. In addition, we postulate that the reason molybdate affects the glucocorticoid receptor is because it mimics an endogenous compound, and this compound appears to be modulator.
